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Contribution 
What does this work add to what is already known?  
 
This work provides comparisons (with reservations) of the effects of several monitoring 
techniques in the two randomized trials in early FGR. 
 
 
What are the clinical implications of this work? 
 
This analysis supports that fetal monitoring for early FGR can best be performed by the 
combination of cCTG and DV Doppler assessment. 
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Abstract  
Objective: To explore the influence on perinatal outcome of different fetal monitoring 
strategies for preterm fetal growth restriction (FGR). 
Design: Cohort analysis of individual participant data from the Growth Restriction 
Intervention Study (GRIT) and Trial of Umbilical and Fetal Flow in Europe (TRUFFLE) studies.  
Setting: European multi-centre trials. 
Population: All women from GRIT (n=238) and TRUFFLE (n=503), randomized between 26 
and 32 weeks.  
Methods: Women were categorized according to their monitoring-intervention method: A. 
immediate delivery (from GRIT), B. delayed delivery using conventional cardiotocography 
(CTG, from GRIT), C. delayed delivery using computerized CTG only (cCTG, from GRIT), D 
delayed delivery using cCTG only (from TRUFFLE) and E. delayed delivery using cCTG and 
ductus venosus (DV) Doppler (from TRUFFLE).  
Primary outcome measure: Survival without impairment at two years. 
Results: Gestational age at delivery and birth weight were similar in both studies. Fetal 
death rate was similar between GRIT and TRUFFLE, but neonatal and late death were more 
frequent in GRIT (18% vs. 6%; p<0.01). The primary outcome was least common in groups A 
(70%; 95% confidence interval [CI] 61-78), and B (69%; 95% CI 57-82), and increased with 
more advanced monitoring in C (80%; 95% CI 68-91) and D (77%; 95% CI 70-84) and was 
highest in E (84%; 95% CI 80-89); (p trend <0.01).  
Conclusions: This analysis supports that fetal monitoring for early FGR can best be 
performed by the combination of cCTG and DV Doppler assessment.  
Trial Registration: GRIT ISRCTN41358726 and TRUFFLE ISRCTN56204499. 
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Introduction 
Fetal growth restriction (FGR) in the early preterm period before 32 weeks is a rare, but 
serious complication due to its association with adverse perinatal outcome. Treatment of 
the underlying condition is impossible and the challenge lies in optimal timing of delivery. 
The risks of prematurity (neonatal complications and impaired neurodevelopment) have to 
be balanced against the risks of prolonged fetal exposure to hypoxaemia and acidaemia, 
possibly resulting in stillbirth and brain damage. Obstetricians use a range of tests of fetal 
wellbeing. However, the sequences of fetal deterioration are difficult to evaluate in humans 
because observational case series of growth restricted fetuses rarely, if ever, include all 
tests of wellbeing. More importantly study outcomes are inevitably “censored” because the 
timing of delivery is subject to the vagaries of parental choice and the managing clinicians.1 
The optimal indication for timing of delivery is still open for debate.2 
Trials in this patient group are hard to conduct. To date, only two large randomised trials 
have evaluated how to time delivery in early preterm FGR: GRIT and TRUFFLE.3, 4 Both have 
been highly cited, but their influence on practice is difficult to measure. Even though GRIT 
recruited 548 women (588 babies) and TRUFFLE recruited 503 women, and both trials 
achieved very high follow-up rates up to two years, the number of participants at any 
specific gestational age, or with similar clinical risk factors was small. Given how clinical 
decisions are so specific for gestational age the available analyses are necessarily 
underpowered.  
In the absence of data from further trials, but while awaiting those, the obvious interim 
solution is meta-analysis of the existing ones. Ideally this should be an individual patient 
data meta-analysis (IPD M-A) and both trial databases are available. However, the 
differences in inclusion criteria and in study period between the two trials precluded such 
an analysis. 
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The objective of the current analysis was to explore the influence on perinatal outcome of 
different fetal monitoring strategies used in these two trials with similar populations 
regarding gestational age and severity of FGR.  
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Methods 
Because the intention was to perform a meta-analysis on trials of fetal monitoring with long-
term infant outcome results we performed a scoping literature search in Pubmed, with the 
terms “(fetal compromise[Title/Abstract] or fetal monitoring[Title/Abstract]) AND (growth 
restriction[Title/Abstract] OR fetal growth[Title/Abstract]) AND (long term[Title/Abstract] 
OR long-term[Title/Abstract] OR wellbeing[Title/Abstract] OR 
neurodevelopment[title/abstract] OR Griffith[Title/Abstract] OR Bayley[Title/Abstract])” and 
with a limit on clinical trials. This confirmed that GRIT and TRUFFLE were the only 
monitoring-intervention studies in early-onset fetal growth restriction.3, 4 Individual 
participant data were retrieved from both trial datasets. Methods of both studies were 
previously described in full and summarized below. 
GRIT 
In GRIT3, 5, 548 pregnant women between 24 and 36 completed weeks were recruited in 69 
European hospitals between 1993-2001. All fetuses had suspected FGR and the inclusion 
criterion was clinical uncertainty about whether immediate delivery was indicated. Fetal 
arterial Doppler and cardiotocography were recorded before inclusion, but interpretation of 
these findings was left to local standards. Ductus venosus Doppler was not used. Women 
were randomly allocated to immediate delivery (n=296) or to delivery, which was delayed 
until the obstetrician was no longer uncertain (n=292). Mode of delivery and monitoring 
strategies for the deferred group were left up to the attending obstetrician. The main 
outcome was death or impairment at or beyond 2 years of age. Impairment was a 
composite outcome comprising any of cerebral palsy, little or no vision, requirement for a 
hearing aid, or a Griffith’s Mental Development Scales General Quotient of 70 or less, 
assessed by a Griffith-trained assessor. For those babies who were not seen personally after 
two years the former three diagnoses were accepted from either parental report or the 
child's family practitioner or paediatrician. The overall rate of death or severe impairment at 
2 years was 17.2% in those with known outcome. There was no statistically significant 
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difference between the groups. A neurological impairment occurred in 6.5% of surviving and 
assessed children. For the purpose of this analysis the original study abnormal endpoint 
definition was used, i.e. survival without impairment at or beyond 2 years of age.  
 
 
TRUFFLE 
In TRUFFLE4, 6 503 pregnant women between 26 and 32 completed weeks were recruited by 
20 European hospitals between 2005-2010. All had fetuses with FGR, defined by elevated 
umbilical artery pulsatility index (PI) and ultrasound biometry. Women were randomized to 
one of three groups where delivery was determined by either reduced short-term variation 
in fetal heart rate using computerized CTG (cCTG), or to one of two criteria based on 
Doppler ultrasound assessment of the ductus venosus waveforms, namely early (PI >95
th 
centile) or late abnormalities (absent or negative A-wave). Criteria were specified in detail 
and included specific cut-offs for STV in all groups, although the intensity of monitoring was 
not prescribed. All ultrasonographers met predetermined criteria for performing ductus 
venosus Doppler measurements. The main outcome was survival without neurological 
impairment at two years. Impairment comprised any of cerebral palsy, severe vision or 
hearing impairment, or a cognitive composite score from the Bayley Scales of Infant and 
Toddler Development (third edition) of less than 85, assessed by an assessor, trained and 
accredited specifically for the trial. For those babies who were not seen personally after two 
years the former three diagnoses were accepted from either parental report or the child's 
family practitioner or paediatrician. The overall rate of death or severe impairment at 2 
years was 18.1% of all infants with a known outcome, with no statistical differences 
between the groups. The overall rate of neurological impairment at 2 years in surviving 
assessed children was 9.7%. This was lower in the DV groups than in the cCTG group.  
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Data strategy 
For this analysis, we used data from the subset of participants in GRIT with singleton 
pregnancy and gestational age between 26 and 32 completed weeks at study entry. From 
TRUFFLE all women were selected, except one where neonatal data were missing. Baseline 
variables, process variables and outcomes were compared between groups, with specific 
emphasis on their relationship with antenatal death and 2-year outcome. We combined 2-
year outcome data, defining ‘survival free of impairment as survival free of cerebral palsy, 
severe visual impairment or hearing loss requiring aids, and either a Griffith Quotient >70 
(GRIT) or Bayley-III (or adjusted Bayley II) Cognitive composite score >85 (TRUFFLE). The 
primary outcome was calculated for all infants with known outcome, including all perinatal 
and late death, but excluding infants lost to two year follow-up. 
Analysis strategy 
Data were classified for different monitoring and intervention strategies: A. immediate 
delivery when fetal condition was uncertain (from GRIT), B. delayed delivery using 
conventional CTG (from GRIT), C. delayed delivery using cCTG with STV calculation (from 
GRIT), D. using cCTG with STV calculation (from TRUFFLE CTG group) and E. delayed delivery 
using cCTG with STV calculation and ductus venosus (DV) Doppler (both DV groups from 
TRUFFLE combined, as results of these groups were not statistically different). A second 
analysis aimed at differences in infant outcome over time. The years of the studies were 
grouped as 1994 to 1997, 1998 to 2001, 2005 to 2007 and 2008 to 2010, dividing both 
studies in a first and second half. 
Parameters for analysis included monitoring strategy classification, year of randomisation 
grouping, gestational age at randomisation in weeks, umbilical artery absent or reversed 
(ARED) flow, and birth weight Z-score. Birth weight Z scores were calculated using an in-
utero fetal weight model developed by Hadlock et al.7 Because in GRIT an estimated fetal 
weight at inclusion was not recorded we included birth weight in the analysis. 
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Statistics 
Baseline characteristics, process variables and outcomes were compared two-sided for 
statistical significance by ANOVA, the Mann–Whitney U-test or Pearson’s chi-square test, as 
appropriate.  
The association of demographic, clinical and diagnostic parameters at study inclusion with 
the endpoints was first explored by univariable analysis. Those parameters that were 
significantly different between infants with normal 2-year outcome and infants with death 
or neurological impairment in univariable analysis were entered in a multivariable logistic 
regression analysis to adjust for association between parameters and to calculate odds 
ratios (OR).7, 8 A regression analysis was planned first without gestational age or birth weight 
and secondly with these parameters, to determine if the odds ratios of intervention strategy 
classification or study period was affected by these parameters by possible collider bias. 
Logistic regression analysis was started with the intervention strategies or with study period 
groups and other parameters were added stepwise, based on probability for the primary 
endpoint (healthy survival at two years). The probability for entry in the model was set at 
0.05 and removal at 0.10. Statistical calculations were performed using Statistical Package 
for the Social Sciences (SPSS program, version 25; IBM Corp., New York, NY, USA).  
Institutional review 
This study was exempted from review by the institutional ethics review boards.  
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Results 
We included 238 women from GRIT and 502 women from TRUFFLE. Gestational age at 
inclusion or at delivery, and birth weight were similar between all subgroups (Table 1). 
Because of the randomization sequence, allocation to different groups was evenly spread 
across the years. More women had absent or reversed umbilical artery (ARED) flow at study 
entry in GRIT than in TRUFFLE (70% vs. 41%; p<0.01). However, if later measurements were 
included rates of umbilical ARED flow were comparable between the groups (on average 
64%). The interval to delivery was shorter in the GRIT delayed delivery groups than in the 
TRUFFLE groups (median 3 days versus 8 days, p<0.01). Fetal death rate was comparable 
between GRIT and TRUFFLE, but neonatal and late death was more frequent in GRIT (18% 
vs. 6%; p<0.01). Fetal death rate was similar in women monitored by conventional CTG 
without STV compared to monitoring by cCTG (both delayed GRIT; 5 vs. 6%), but perinatal 
mortality was lower in the cCTG GRIT group (13% vs 23%, not statistically significant). The 
primary outcome (survival without neurological impairment at 2 years) was worst in the 
immediate delivery and CTG without STV groups, intermediate in the cCTG groups and best 
in the cCTG + DV strategy group (Pearson chi-square <0.01). This is also graphically 
presented in figure 1 showing a decreasing perinatal death rate across groups, most 
apparent for those included at the lowest gestational age group (26-27 weeks). A similar 
trend was observed when data were grouped for year of randomization (Pearson chi-square 
<0.01) (figure 2). Other parameters that were significantly associated with the primary 
outcome were gestational age at randomization, umbilical ARED flow, birth weight and birth 
weight Z-score. 
Because the study periods of GRIT and TRUFFLE differed (1993-2001 versus 2005-2010) and 
study period and intervention group classification were highly associated (Pearson 
correlation 0.82) it was not justified to combine these in one regression analysis. We 
therefore performed a separate regression analysis for monitoring groups and for year of 
inclusion with the other parameters that were significantly associated with the primary 
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outcome, except birth weight and birth weight Z-score. Birth weight and birth weight Z-
score were omitted because they were correlated with both gestational age and ARED flow. 
Odds ratios of monitoring strategy and study period were not affected by addition of 
gestational age, but the area under the curve (AUC) of a receiver operating characteristic 
(ROC) curve of the regression model increased from 0.63 to 0.69. Odds ratios for the model 
are shown in figure 3a and b. Gestational age at inclusion and umbilical ARED flow, which 
both are measures for the severity of FGR, were highly associated with the primary 
outcome. Year of inclusion and monitoring strategy had a similar, moderate effect.   
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Discussion 
Main findings 
We observed a trend for improved long-term infant outcome with less neonatal death and 
less neurological impairment using more advanced fetal monitoring strategies after 
adjustment for severity of FGR using gestational age at delivery and umbilical ARED flow.  
Strengths and Limitations 
This analysis was on the outset intended to perform a meta-analysis with individual patient 
data. Conventional meta-analysis proved impossible, because the inclusion selection and 
the type of interventions were entirely different.  
Although inclusion criteria differed between GRIT and TRUFFLE, the study populations are 
very similar with regard to gestational age, birthweight and birth weight Z-score. 
Absent/reversed umbilical Doppler flow at inclusion was more frequent in GRIT. GRIT 
participants were included when there was uncertainty regarding the necessity of delivering 
the baby and were at inclusion probably in a later stage of the pathological process of FGR 
than TRUFFLE participants. As a result of this, in TRUFFLE the interval of inclusion to delivery 
was longer and with later Doppler measurements ARED flow became as frequent as in GRIT.  
A difficult problem was that the trials were performed during subsequent time periods and 
that it was impossible to separate outcome improvement due to advances in obstetric and 
neonatal care from the monitoring strategy differences between the trials. On statistical 
analysis both study period and trial allocation were highly correlated. Both seemed to have 
an effect, but the proportional contribution of these parameters to the primary outcome 
could not be determined exactly.  
Birth weight and gestational age have a potential for collider stratification bias: they are not 
independent parameters in a population with early preterm FGR. They are influenced by 
severity of FGR, monitoring methods and the decision to deliver the baby at a certain 
moment. Of course, it would have been better if more data on underlying pathology of FGR 
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were known and available to improve outcome prediction. Unfortunately, except from 
Doppler data, there are no appropriate markers for underlying pathology of FGR. Therefore, 
gestational age in this study should be regarded as a proxy for the severity of FGR, and not 
as an independent variable. The study population is rather uniform in its selection through 
functional Doppler markers of FGR and we expect that this resulted in a similarity of 
underlying pathologies that caused FGR in the intervention groups. A further argument that 
collider bias by gestational age is unlikely is the observation that a regression analysis with 
or without gestational age resulted in similar odds ratios for monitoring strategy or study 
period, while the AUC of the ROC curve for the model increased by addition of gestational 
age. 
The two studies used two different tests to assess neurodevelopmental outcome, Griffiths 
General Quotients in GRIT and Bayley Cognitive Composite scores in TRUFFLE, and used 
different cut offs commensurate with prevailing practice. By using a cut-off <85 in TRUFFLE, 
and a stricter less prevalent cut-off of <70 in GRIT it would be unlikely that differences in 
developmental outcome were inflated in advantage of TRUFFLE.9 This supports our 
conclusion that outcome was really better in TRUFFLE DV groups. 
GRIT was a study on delivery in women with FGR when the clinician was uncertain whether 
to deliver the baby or not. The attending obstetrician was free to decide on fetal monitoring 
methods and the mode of delivery. TRUFFLE was designed to compare different monitoring 
strategies and delivery criteria were specifically defined for each strategy. Cut-offs for STV 
had been defined based on the studies of Dawes et al., based on associations with fetal 
acidaemia.10 DV Doppler cut-offs were substantiated by longitudinal studies into monitoring 
parameters and adverse perinatal outcomes.1, 11 However, the minimal frequency of 
monitoring was specified liberally (DV Doppler once weekly, cCTG twice a week). Lack of a 
fixed, frequent schedule for monitoring in TRUFFLE and the complete absence of such data 
from GRIT precludes a secondary longitudinal analysis of monitoring data, which could have 
given more information of their relative impact on decision making.  
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In both studies deliveries were indicated by other criteria than fetal distress. In GRIT 
indication for delivery was not included in the database, while we know that in TRUFFLE 
30% were delivered outside the pre-specified monitoring criteria.12 Also, there were 
insufficient data regarding co-interventions such as corticosteroids (probably in nearly all 
patients) and magnesium (probably only in a few patients for eclampsia prevention, fetal 
neuroprotection was not used then). These restrictions hamper the combined analysis of 
the data targeted at the effect of the monitoring strategies.  
Our intention to test the superiority of cCTG over conventional CTG was only partly 
successful. Only few articles have compared the predictive value of cCTG with visual 
inspection of the CTG, all use only short-term outcomes and are underpowered for perinatal 
outcomes. Turan et al. described monitoring parameters in a cohort of 56 growth-restricted 
fetuses and showed a slightly better correlation of low STV with low umbilical cord pH as 
compared to traditional CTG.15 Another study showed no significant relationship between 
both methods and fetal or neonatal survival.16 To our knowledge, there are no published 
data comparing the efficacy of cCTG versus standard CTG using visual inspection. Currently, 
probably due to the limited association with fetal hypoxemia and acidaemia of cCTG,17, 18 
there is significant practice variation in the use of cCTG. 
Interpretation 
We observed an improvement of infant outcome over time and by advancement of fetal 
monitoring. This correlation is, of course, not only statistical. It is logical that advancement 
in obstetric and neonatal care over the past 20 years have an effect and that advancements 
in fetal monitoring methods form a part of this.  
In the delayed GRIT group with cCTG infant outcome was better than in the group with 
visual assessment, although this difference was not statistically significant and might have 
been caused by other differences between centres that used cCTG and those that did not. 
The main advantage of cCTG is that it provides a numerical result, which allows for a strictly 
protocolled intervention decision, as applied in TRUFFLE strategy. Its use is therefore 
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essential for future intervention trials. However, it has not been proven to be superior in a 
head to head comparison. 
Conclusion 
This comparative analysis supports the hypothesis that fetal monitoring for early preterm 
FGR can best be performed by the combination of cCTG and DV Doppler assessment.  
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Figure legends 
 
Figure 1: Perinatal death rate and neurodevelopmental impairment at 2 years of age 
specified for group classification and gestational age at randomisation of women 
participating in GRIT and TRUFFLE. 
 
Figure 2: Perinatal death rate and neurodevelopmental impairment at 2 years of age 
specified for period and gestational age at randomisation of women participating in GRIT 
and TRUFFLE. 
 
Figure 3: Odds ratios with 95% confidence interval for survival without neurological 
impairment at 2 years, calculated by multivariable regression analysis, with:  
A – Monitoring group classification: AUC 0.69 (95% CI 0.64 to 0.74)  
B – Year of inclusion: AUC 0.68 (95% CI 0.63 to 0.73) 
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Table 1: Perinatal and outcome characteristics specified for fetal monitoring strategy of 
women participating in GRIT and TRUFFLE 
A. immediate delivery when fetal condition was uncertain (from GRIT), B. delayed delivery 
using CTG without STV calculation (from GRIT), C. delayed delivery using cCTG-STV 
calculation (from GRIT)), D. delayed delivery using cCTG-STV calculation (from TRUFFLE CTG 
group) and E. delayed delivery using cCTG-STV and DV assessment (both DV groups from 
TRUFFLE combined). 
 
GRIT TRUFFLE 
Total Immediate 
delivery 
(A) 
Delayed delivery 
vCTG no STV 
(B) 
cCTG-STV 
(C) 
cCTG-STV 
(D) 
cCTG-STV and 
DV (E) 
N 121 62 55 165 337 740 
Nulliparous 74 (61%) 33 (53%) 33 (60%) 100 (61%) 218 (65%) 458 (62%) 
Gestational age at inclusion 29.5  (28.5 to 31.0) 
29,5  
(28.5 to 31.5) 
29.5  
(28.5 to 30.5) 
29.2  
(27.9 to 30.1) 
29.2  
(27.9 to 30.4) 
29.5  
(28.1 to 30.5) 
Interval to delivery (days) ‡ 0 (0 to 1) 4 (2 to 8) 2 (1 to 8) 7 (2 to 17) 8 (3 to 17) 5 (1 to 14) 
Umbilical ARED flow inclusion ‡ 85 (70%) 44 (71%) 37 (67%) 61 (37%) 147 (44%) 374 (51%) 
Umbilical ARED flow any time 85 (70%) 44 (71%) 37 (67%) 94 (57%) 210 (62%) 470 (64%) 
Fetal death 2 (2%) 3 (5%) 3 (6%) 2 (1%) 10 (3%) 20 (3%) 
Live born 119 (98%) 59 (95%) 52 (94%) 163 (99%) 327 (97%) 720 (97%) 
Gestational age at delivery 30.5  (28.6 to 31.5) 
30.6  
(29.0 to 32.4) 
30.7  
(29.6 to 31.6) 
30.6  
(29.0 to 32.0) 
30.7  
(29.3 to 32.3) 
30.6  
(29,1 to 31.9) 
Birth weight 880  (740 to 1100) 
920  
(745 to 1085) 
928  
(733 to 1068) 
965  
(800 to 1115) 
990  
(806 to 1200) 
953  
(780 to 1160) 
Birth weight Z-score -3.3  (-3.9 to -2.4) 
-3.3  
(-4.3 to -2.7) 
-3.5  
(-4.1 to -2.8) 
-3.3  
(-3.8 to -2.7) 
-3.3  
(-3.8 to -2.8) 
-3.3  
(-3.8 to -2.8) 
Neonatal death‡ 23 (19%) 11 (19%) 4 (8%) 10 (6%) 17 (5%) 65 (9%) 
Late death < 2 years& 3 (3%) 0 (---) 1 (2%) 1 (1%) 1 (0%) 6 (1%) 
Evaluated at 2 years 91 (98%) 45 (94%) 46 (98%) 131 (86%) 271 (88%) 584 (90%) 
Severe impairment†* 4 (4%) 2 (4%) 1 (2%) 6 (4%) 3 (1%) 16 (3%) 
Abnormal development * 8 (9%) 4 (9%) 3 (7%) 20 (15%) 19 (7%) 54 (9%) 
Composite primary outcome 
Alive with normal development 
at two years ‡ 
% of known outcome; (95% CI) # 
 
83 
 
70%; 
(61% to 78%) 
 
41 
 
69%;  
(57% to 82%) 
 
43 
 
80%;  
(68% to 91%) 
 
111 
 
77%;  
(70% to 84%) 
 
252 
 
84%; 
(80% to 89%) 
 
530 
 
79%; 
(75% to 82%) 
‡ Distribution differs across the categories (Kruskal-Wallis test or Pearson Chi-Square, p < 0.05) 
& Late deaths = death after first discharge home, and before the age of two years 
* Percentage of evaluated infants  
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† Severe impairment of hearing or vision, or cerebral palsy 
# Percentage of all infants with known outcome, including perinatal death 
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Figure 3A: Odds ratios with 95% confidence interval for survival without neurological impairment at 2 years, 
calculated by multivariable regression analysis, with monitoring group classification: AUC 0.69 (95% CI 0.64 
to 0.74) 
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Figure 3B: Odds ratios with 95% confidence interval for survival without neurological impairment at 2 years, 
calculated by multivariable regression analysis, with year of inclusion: AUC 0.68 (95% CI 0.63 to 0.73) 
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